Gentamicin Sulfate
Sponsors
University of Southern California, Tel-Aviv Sourasky Medical Center, University of Michigan, University of Louisville, University of Oxford
Conditions
Epidermolysis BullosaHereditary Hypotrichosis SimplexJunctional Epidermolysis BullosaNeurogenic BladderPelvic Organ ProlapsePneumoniaPostoperative Urinary Tract InfectionRecessive Dystrophic Epidermolysis Bullosa
Phase 1
Gentamicin for RDEB
CompletedNCT03012191
Start: 2017-02-02End: 2018-08-31Updated: 2019-07-23
Gentamicin for Junctional Epidermolysis Bullosa
RecruitingNCT03526159
Start: 2018-06-01End: 2020-08-31Target: 6Updated: 2020-04-07
Topical Gentamicin Nonsense Suppression Therapy of EB
CompletedNCT04644627
Start: 2020-12-01End: 2022-05-01Updated: 2022-05-03
Phase 2
Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN
NCT03492866
Start: 2018-04-30End: 2019-04-30Target: 8Updated: 2018-04-10
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
CompletedNCT03503513
Start: 2018-08-24End: 2023-09-30Updated: 2024-06-25
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
CompletedNCT03931408
Start: 2019-02-19End: 2020-12-30Updated: 2025-01-29
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
CompletedNCT04246996
Start: 2020-01-29End: 2021-12-05Updated: 2022-11-08